Market News & Trends
SGS enhances bioanalytical capacity with Saint-Benoît laboratory expansion
Baar – SGS, the world’s leading testing, inspection and certification company, has expanded its Saint-Benoît laboratory, a strategic site dedicated to pharmaceutical bioanalysis and drug…
Grifols announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in patients with emphysema due to alpha-1 antitrypsin deficiency
Barcelona, Spain, – Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced the completion of the clinical portion of SPARTA (Study of ProlAstin-C Randomized Therapy…
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
PRINCETON, N.J.- Bristol Myers Squibb today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately…
Kupando Announces First Patient Dosed in Phase 1 Clinical Study of Lead Candidate KUP101 in Advanced Solid Tumors
SCHÖNEFELD, Germany, -- Kupando, a pioneering biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology…
FDA Approves the First Ever mRNA Flu Vaccine From Moderna
The FDA approved Moderna’s mRNA vaccine, mFlusiva, to prevent seasonal influenza in adults 50 years of age and older. This marks the first ever approval…
ILC Dover Introduces EZJetFlo Technology to Transform Powder Dissolution and Mixing in Biopharmaceutical Manufacturing
FREDERICA, Del., -- ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical, pharmaceutical, and medical device markets,…
LTS Breaks Ground on Major Expansion to Advance Drug Delivery Innovation and North American Growth
West St. Paul, Minnesota / Andernach, Germany, – LTS Lohmann Therapie-Systeme AG (LTS), a leading partner in innovative drug delivery technologies, today celebrated the groundbreaking…
Enzene launches NeX, a comprehensive suite of solutions to enable cost-efficient, high-yielding local biomanufacturing
Pune, India - Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX, a transformative end-to-end partnership model…
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million
CAMBRIDGE, Mass., Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced the completion…
Tasrif Pharmaceutical Granted Second U.S. Patent for CD155-Targeting Antibody Developed with Abzena’s Humanization & Immunogenicity Platforms
Abzen’s customer Tasrif Pharmaceutical, LLC announced the grant of its second U.S. Patent, expanding its intellectual property targeting the Poliovirus Receptor (CD155/PVR). Together with Tasrif’s…
Abzena’s Customer Promatix Awarded Innovate UK Biomedical Catalyst Grant to Advance Cis-Bispecific ADC
Promatix Biosciences Ltd, an emerging UK-based biotechnology company developing innovative new classes of cancer therapies using cis-bispecific antibodies, announced that it has been awarded a…
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, today announced…
Pace Life Sciences Announces Compliant US FDA Inspection of Operations in Research Triangle Park, NC
RALEIGH, NC Pace® Life Sciences, a U.S.-based, FDA-registered GMP analytical testing laboratory and full-service contract research, development, and manufacturing organization (CDMO), and a Division of Pace®,…
Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
CAMBRIDGE, Mass., -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced that one of its D-MAV candidates demonstrates in…
ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division
Garching / Munich, Germany and Princeton, New Jersey, - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today introduced Lumara Bio as a…
Nemera and SCHOTT Pharma deliver verified pen injector platform with sterile cartridge system
To support the industry shift from hospital to homecare including a more convenient drug administration for patients, Nemera, a world-leading provider of drug delivery device…
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Basel, Switzerland, and London, UK – Lonza, a contract development and manufacturing organization (CDMO), and Engitix, a global leader in ECM-based drug discovery and development,…
Samsung Biologics announces all-cash offer to acquire PolyPeptide
INCHEON, South Korea, -- Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital…
Eli Lilly Makes $2.8 Billion Neuropsychiatry Acquisition
Another major move from Lilly - this time putting real capital behind psychedelics as a legitimate mental health treatment class. Why this matters: Treatment-resistant depression…
CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development
MONTREAL, CANADA, – CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced the launch of its Global Digital Pathology and AI Consortium,…
